Disclosure Of First-Time Adoption [Text Block]

ChemoMetec - Filing #1366642

Concept	As at 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	As at 2023-06-30	As at 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	As at 2023-06-30	2022-07-01 to 2023-06-30	As at 2023-06-30	As at 2022-07-01	As at 2022-07-01	As at 2022-07-01	As at 2022-07-01	As at 2022-07-01	As at 2022-06-30	As at 2022-06-30	2021-07-01 to 2022-06-30	2021-07-01 to 2022-06-30	2021-07-01 to 2022-06-30	As at 2022-06-30	As at 2022-06-30	2021-07-01 to 2022-06-30	2021-07-01 to 2022-06-30	As at 2022-06-30	As at 2021-07-01	As at 2021-07-01	As at 2021-07-01	As at 2021-07-01	As at 2021-07-01
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	18,000 DKK	—	—	104,415 DKK	411,207 DKK	—	—	533,042 DKK	—	17,402 DKK	- DKK	357,205 DKK	339,777 DKK	26,000 DKK	17,402 DKK	339,777 DKK	26,000 DKK	—	—	—	- DKK	357,205 DKK	—	—	17,402 DKK	264,977 DKK	69,610 DKK	4,000 DKK	177,961 DKK	17,402 DKK
Comprehensive income	—	104,415 DKK	71,497 DKK	—	—	8,000 DKK	- DKK	—	175,904 DKK	—	—	—	—	—	—	—	—	159,943 DKK	- DKK	- DKK	—	—	22,000 DKK	159,921 DKK	—	—	—	—	—	—
Profit (loss)	—	104,415 DKK	74,252 DKK	—	—	- DKK	- DKK	—	178,667 DKK	—	—	—	—	—	—	—	—	159,469 DKK	- DKK	- DKK	—	—	- DKK	159,469 DKK	—	—	—	—	—	—